SEC Form 4 · accession 0001093557-18-000092
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Robert Pacelli
Officer — EVP, Strategy & Corp. Dev.
Period of report
May 10, 2018
Accepted (ET)
May 11, 2018 · 8:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 10, 2018 | M | 2,855 | $7.63 | A | 128,685 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $7.63 | May 10, 2018 | M | 2,855 | D | May 19, 2009 | May 19, 2018 | Common Stock | 2,855 | 0 | D |
Explanation of responses
- F1Included in this number are 69,509 unvested restricted stock units, 38,502 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 18,340 of which were granted on March 8, 2017 and shall vest through March 8, 2020, and 12,667 of which were granted on March 8, 2016 and shall vest through March 8, 2019.